mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-06 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.0005 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.0006 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.002 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |